Skip to content
To the full analysis

Sabra Health Care REIT stock: balance sheet and debt

SBRA
$20.56Closing price of 12 Nov 2026MEQIRI Score 50 out of 100

Sabra Health Care REIT has a debt to equity ratio of 0.9 and an interest coverage of 2.4x.

Daily figure as of 13 Nov 2026

Debt / Equity
0.9
Interest coverage
2.4x
Current ratio
0.56
Cash & equivalents
$71.54M
Total assets
$5.49B
Equity ratio
51.4%
Goodwill and intangible assets
$65.32M
not split out
Net debt
$2.48B

Total assets and equity ratio

How large the balance sheet of Sabra Health Care REIT, Inc. is, how much of it is equity and how much is goodwill from acquisitions.

Equity ratio

Figures as a table
YearTotal assetsGoodwill and intangible assetsof which goodwillEquity ratioNet debt
2010$599.5Mnot reported separatelynot reported separately29.6%$312.2M
2011$749.65Mnot reported separatelynot reported separately43.6%$341.15M
2012$916.88Mnot reported separatelynot reported separately33.3%$558.39M
2013$1.2Bnot reported separatelynot reported separately38.4%$686.92M
2014$2.06Bnot reported separatelynot reported separately45.6%$1.03B
2015$2.49Bnot reported separatelynot reported separately42.4%$1.39B
2016$2.27B$26.25Mnot split out44.8%$1.19B
2017$7.03B$167.12Mnot split out48.9%$2.88B
2018$6.67B$131.1Mnot split out48.8%$3.18B
2019$6.07Bnot reported separatelynot reported separately57.5%$2.44B
2020$5.99Bnot reported separatelynot reported separately57.0%$2.37B
2021$5.97B$54.06Mnot split out56.6%$2.33B
2022$5.75B$40.13Mnot split out53.2%$2.5B
2023$5.39B$30.9Mnot split out52.0%$2.41B
2024$5.3B$27.46Mnot split out51.7%$2.38B
2025$5.49B$65.32Mnot split out51.4%$2.48B

The equity ratio divides total equity, including non-controlling interests, by total assets. Net debt is debt minus cash and short-term investments; a negative figure means cash exceeds debt. In years without separate goodwill, the table shows the sum of goodwill and intangible assets, because the data do not list goodwill separately there.

Equity and debt

What the company owns and owes

  • Cash & equivalents
  • Equity
  • Debt
Figures as a table
YearCash & equivalentsEquityDebtDebt / Equity
2010$74.2M$177.5M$386.4M2.18
2011$42.25M$326.57M$383.4M1.17
2012$17.1M$305.49M$575.49M1.88
2013$4.31M$460.16M$691.23M1.5
2014$61.79M$941.87M$1.09B1.16
2015$7.43M$1.05B$1.4B1.33
2016$25.66M$1.02B$1.21B1.19
2017$518.63M$3.43B$3.39B0.99
2018$50.23M$3.25B$3.23B0.99
2019$39.1M$3.49B$2.48B0.71
2020$59.08M$3.41B$2.43B0.71
2021$112M$3.38B$2.44B0.72
2022$49.31M$3.06B$2.55B0.83
2023$41.29M$2.8B$2.45B0.87
2024$60.47M$2.74B$2.44B0.89
2025$71.54M$2.82B$2.55B0.9

Data status and sources

Score
Daily value of 13 Nov 2026, recalculated nightly
Price
Closing price of 12 Nov 2026
Latest annual report
Fiscal year 2025, period end 31 Dec 2025
Source
Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.

Mandatory disclosures for this rating

  • ; time horizon around 12 months
  • Rated Neutral, published since 7 Nov 2026 (in the score history since 4 Nov 2026)
  • Valuation signal Fairly valued since 7 Nov 2026
  • End-of-day prices, metrics cached for up to 24 hours
  • Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
  • Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
  • Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.

MEQIRI counts visits without cookies. With your consent we remember for 90 days where you came from, also in your account, count page changes and time on page, recognise your next visit and load the Meta Pixel, which measures our advertising. You can withdraw your consent at any time under Cookie settings. Privacy